Value of CT-Guided Percutaneous Irreversible Electroporation Added to FOLFIRINOX Chemotherapy in Locally Advanced Pancreatic Cancer: A Post Hoc Comparison
Authors:
- 1 October 2020
- journal article
- research article
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 31 (10) , 1600-1608
Abstract
No abstract availableKeywords
Funding Information
- KWF Kankerbestrijding
This publication has 20 references indexed in Scilit:
- Treatment of 200 Locally Advanced (Stage III) Pancreatic Adenocarcinoma Patients With Irreversible ElectroporationAnnals of Surgery, 2015
- Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2015
- Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic CancerAnnals of Surgery, 2015
- Irreversible Electroporation in Locally Advanced Pancreatic Cancer: Potential Improved Overall SurvivalAnnals of Surgical Oncology, 2012
- Locally Advanced Pancreatic CancerSeminars in Oncology, 2012
- A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinomaBMC Cancer, 2012
- Pancreatic cancerThe Lancet, 2011
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerNew England Journal of Medicine, 2011
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Pancreatic CarcinomaNew England Journal of Medicine, 1992